Xcout IntelSign inSubscribe

Scopio Labs competitors & alternatives

Medical DevicesIsrael

The 12 closest competitors and alternatives to Scopio Labs among medical devices companies — ranked by similarity to what Scopio Labs actually does, not by market-cap band.

12Competitors listed

Subscribe to see Scopio Labs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Scopio Labs

Scopio Labs provides digital hematology imaging platforms and AI-powered analysis applications for peripheral blood smears and bone marrow aspirates. The company's technology enables clinical laboratories to fully digitize morphology workflows, view high-resolution 100x scans remotely, and collaborate across networks.

Scopio Labs at a glance

Scopio Labs is a medical devices company headquartered in Israel, founded in 2014. Its most recent funding round, Series B, raised $16M in April 2020. Xcout tracks 13 named people at Scopio Labs, including Ronen Tsimerman (Chief Financial Officer).

Scopio Labs leadership

  • Ronen TsimermanChief Financial Officer
  • Amy MeitusChief Product Officer
  • Amir FarhiChief Commercial Officer
  • Amir ShlomovichChief Operations Officer
  • Iris GetzChief Strategy Officer
  • Tali CohenChief People Officer

7 more named people on record for Scopio Labs, with roles, board committees and tenure — see the full roster →

Scopio Labs funding rounds

Every round on record:

DateRoundAmountInvestors
Series B$16M1 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Scopio Labs competitors

Ranked by semantic similarity — how close each company is to Scopio Labs by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

BIO VIEWBIOV · Medical DevicesRehovot, Israel
63% matchPublic

Similar medical devices company

Bio-View Ltd, founded in 2000 and headquartered in Rehovot, Israel, is a developer, manufacturer, and global distributor of advanced automated cell imaging and analysis systems. These sophisticated solutions are utilized by clinical and research laboratories worldwide, specifically in the fields of cytology, cytogenetics, and pathology. The company's extensive product lineup includes: Accord: A semi-automated fluorescent imaging and analysis workbench microscope station. Accord Plus: An automatic fluorescent imaging system capable of real-time scanning, analysis, and sorting of diverse FISH (Fluorescence In Situ Hybridization) samples. Allegro Plus: Another automatic fluorescent imaging system engineered to pinpoint various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. DUET-3: An imaging and analysis platform featuring an automated barcode reader, which streamlines the processing of multiple test types within a single scan batch. DeNovo: An automated scanning system dedicated to the precise detection, analysis, and characterization of circulating tumor cells found in peripheral blood. Solo Workstation & Solo Touch Workstation: These are offline and standalone workstations, respectively, providing advanced tools for reviewing and analyzing test results remotely from the microscope. SoloWeb: A comprehensive web-based solution that enables remote analysis, reporting, and expert consultation on cases scanned using Bio-View's systems. Furthermore, Bio-View Ltd has established a strategic partnership with ANGLE plc to jointly develop a liquid biopsy circulating tumor cell HER2 assay, specifically targeting breast cancer.

Market cap$4M
Employees31
BIO VIEW competitors & alternatives →
シスメックス6869 · Medical DevicesKobe, Japan
62% matchPublic

Similar medical devices company

Sysmex Corporation, headquartered in Kobe, Japan, and established in 1968 (originally known as TOA Medical Electronics Co., Ltd. until its rebranding in October 1998), specializes in the development, manufacturing, and global distribution of advanced diagnostic instrumentation, chemical reagents, and associated software. Its comprehensive product portfolio addresses various diagnostic needs. In hematology, it offers instruments for both three-part and five-part white blood cell differentiation, alongside efficient transport systems designed for high-volume laboratory testing. For urinalysis, the company provides systems capable of analyzing urine formed sediment. Its offerings extend to automated immunochemistry systems, which are adept at performing assays with minute sample quantities, complemented by reagents for detecting infectious diseases and tumor markers. Sysmex also manufactures flow cytometers, crucial for the analysis involved in diagnosing conditions such as leukemia, malignant lymphoma, and HIV/AIDS. Beyond these core areas, the company is deeply involved in oncology diagnostics, developing systems for detecting cancer lymph node metastasis and cancer genome profiling, as well as offering cytogenetic testing and specialized lab assay services. Sysmex also contributes to digital medicine through the development and sale of software for diagnostic information systems, alongside the creation, operation, and maintenance of IT solutions, platforms, and applications in this field. Its activities further encompass the development and sale of nucleic acid analogs, the full lifecycle management (marketing, development, design, manufacture, sale, and after-sales support) of medical robots, and the distribution and post-sales support for medical devices and reagents used in biotechnology, medical technology, and molecular cell analysis. Sysmex serves a diverse client base, including national, public, and private hospitals, universities, research institutes, and other medical facilities. With a robust international presence, the company exports its products to approximately 190 countries worldwide. Demonstrating its commitment to innovation, Sysmex Corporation maintains a strategic alliance with QIAGEN N.V. for the collaborative development and commercialization of cancer companion diagnostics utilizing Plasma-Safe-SeqS technology.

Market cap$7B
Employees10,861
シスメックス competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Scopio Labs and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Scopio Labsand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →